share_log

復宏漢霖:內幕消息公告 - HLX02(曲妥珠單抗,美國商品名:HERCESSI)獲美國食品藥品管理局(FDA)批准用於乳腺癌輔助治療、轉移性乳腺癌及轉移性胃癌治療

HENLIUS: INSIDE INFORMATION ANNOUNCEMENT - HLX02 (TRASTUZUMAB-STRF, PROPRIETARY NAME IN THE UNITED STATES: HERCESSI) FOR THE TREATMENT OF ADJUVANT BREAST CANCER, METASTATIC BREAST CANCER AND METASTATIC GASTRIC CANCER APPROVED BY THE UNITED STATES FOOD AND DRUG ADMI

Hong Kong Stock Exchange ·  Apr 26 00:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more